Literature DB >> 28913757

Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.

Vide Popovic1, Dragan Arar1, Dragica Roso Popovic2, Igor Barisic3,4, Marija Tonkic3,5, Irena Peric1,3, Anita Novak3,5, Zana Rubic3,5, Vera Katalinic-Jankovic6, Mateja Jankovic Makek7,8, Ivana Goic-Barisic9,10,11.   

Abstract

We report a case of cavitary pulmonary disease caused by Mycobacterium shimoidei in 67-year-old female with history of asthma. Even though susceptibility testing was not available, choice of treatment regimen (streptomycin, rifampicin, ethambutol, and clarithromycin), based on a few cases with favorable outcome reported in the literature, resulted with an excellent clinical, microbiological, and radiological response. This is the first report of pulmonary disease caused by M. shimoidei, but also the first ever isolation of M. shimoidei in Croatia.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28913757     DOI： 10.1007/s12223-017-0548-1

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  22 in total

1.  A possible new pathogen of group iii Mycobacteria.

Authors:  M Tsukamura; H Shimoide; W B Shaefer
Journal:  J Gen Microbiol       Date:  1975-06

2.  Characterisation of a new isolate of Mycobacterium shimoidei from Finland.

Authors:  Pirkko Koukila-Kähkölä; Lars Paulin; Eljas Brander; Erik Jantzen; Mirja Eho-Remes; Marja-Leena Katila
Journal:  J Med Microbiol       Date:  2000-10       Impact factor: 2.472

3.  Mycobacterium shimoidei: first reported isolate in Canada.

Authors:  M A Miller; D Eymard; L Thibert
Journal:  Can Dis Wkly Rep       Date:  1991-01-19

Review 4.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 5.  [A case of pulmonary Mycobacterium shimoidei infection].

Authors:  Satoshi Takayama; Shinichiro Tominaga; Yoshikazu Tsukada; Minoru Ohkochi; Naohiko Inase
Journal:  Kekkaku       Date:  2006-08

Review 6.  Identification of Mycobacterium shimoidei by molecular techniques: case report and summary of the literature.

Authors:  B Mayall; V Gurtler; L Irving; A Marzec; D Leslie
Journal:  Int J Tuberc Lung Dis       Date:  1999-02       Impact factor: 2.373

7.  [Occurrence of Mycobacterium shimoidei in West Germany].

Authors:  S Rüsch-Gerdes; E Wandelt-Freerksen; K H Schröder
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1985-02

8.  Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy.

Authors:  Masayuki Hojo; Motoyasu Iikura; Satoshi Hirano; Haruhito Sugiyama; Nobuyuki Kobayashi; Koichiro Kudo
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

9.  Identification of Mycobacterium shimoidei in a tuberculosis-like cavity by 16S ribosomal DNA direct sequencing.

Authors:  R Heller; B Jaulhac; P Charles; D De Briel; V Vincent; C Bohner; Y Piémont; H Monteil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

10.  Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia.

Authors:  M Jankovic; M Samarzija; I Sabol; M Jakopovic; V Katalinic Jankovic; L Zmak; B Ticac; A Marusic; M Obrovac; J van Ingen
Journal:  Int J Tuberc Lung Dis       Date:  2013-06       Impact factor: 2.373
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.